title: Effect of inhibition of hepatic fatty acid oxidation on metabolic and hormonal responses to exercise in rats.
abstract: The purpose of the present study was to assess the effects of 2-mercaptoacetate (MA), an inhibitor of hepatic fatty acid oxidation, on the metabolic and pancreatic hormone response to a prolonged (3 h) swimming exercise. All rats were first adrenodemedullated and were either submitted for 3 weeks to a normal (5% fat) or a medium-fat diet (MF; 18% fat). After being submitted to an exercise swimming habituation programme for one week, rats under both dietary conditions were either injected with a bolus dose of MA (600 mumol/kg; ip) or with a saline solution. MA and saline injected rats were either sacrificed after a 3-h swimming exercise or after a 3-h resting period. Administration of MA was associated with a lower level of beta-hydroxybutyrate after exercise in rats fed the MF diet, higher resting and exercising blood glucose levels in rats fed the MF diet, and higher resting and exercising levels of hepatic glycogen in rats fed a normal diet. There were, however, no significant effects of MA on free fatty acid, insulin, glucagon, epinephrine, and norepinephrine concentrations in both dietary conditions either at rest or after exercise. Therefore, the present data do not provide any evidence that the administration of MA, an inhibitor of hepatic fatty acid oxidation, influences the pancreatic hormonal response to exercise. There was also no evidence of a lowering effect of MA on blood glucose levels during exercise.
authors.affiliation: Département d'éducation physique, Université de Montréal, Québec, Canada.
authors.forename: J M
authors.initials: JM
authors.lastname: Lavoie
authors.forename: L
authors.initials: L
authors.lastname: Bolduc
authors.forename: R
authors.initials: R
authors.lastname: Hélie
authors.forename: R
authors.initials: R
authors.lastname: Bergeron
authors.forename: S
authors.initials: S
authors.lastname: Lafond
authors.forename: S
authors.initials: S
authors.lastname: Cardin
authors.forename: F
authors.initials: F
authors.lastname: Trabelsi
authors.forename: N
authors.initials: N
authors.lastname: Yamaguchi
mesh_terms: D020155:3-Hydroxybutyric Acid; D000313:Adrenal Medulla / Q000502:physiology / Q000601:surgery; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D005227:Fatty Acids / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005934:Glucagon / Q000097:blood; D006003:Glycogen / Q000378:metabolism; D006885:Hydroxybutyrates / Q000097:blood; D007328:Insulin / Q000097:blood*; D008099:Liver / Q000378:metabolism*; D008297:Male; D010084:Oxidation-Reduction / Q000187:drug effects; D010179:Pancreas / Q000378:metabolism*; D010805:Physical Conditioning, Animal / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013550:Swimming / Q000502:physiology; D013864:Thioglycolates / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D005227:Fatty Acids; D006885:Hydroxybutyrates; D007328:Insulin; D013864:Thioglycolates; C017487:2-mercaptoacetate; D006003:Glycogen; D005934:Glucagon; D020155:3-Hydroxybutyric Acid